Mounjaro & Rybelsus are both approved for type 2 diabetes in the UK. We compare their effectiveness, side effects, & which might suit you best.

Wegovy and Ozempic are the same drug: semaglutide, but are approved for different purposes. Compare their dosing, effectiveness, and which might suit you.

Ozempic and Rybelsus are medications approved for people living with type 2 diabetes in the UK. But, how do they compare? Find out in our guide here.

Comparing Mounjaro and Trulicity for type 2 diabetes: how they work, weight loss evidence, side effects, and which might suit you better.

Ozempic and Trulicity both treat type 2 diabetes and can cause weight loss, but neither is approved for weight management in the UK. Compare them here.

Ozempic and Saxenda both treat type 2 diabetes in the UK but work differently. Compare their effectiveness, side effects, and key differences.

Mounjaro produces 20.2% weight loss vs 13.7% with Ozempic's sister drug Wegovy in a head-to-head trial. Compare evidence, side effects, and UK costs.

Mounjaro produces 15-22% weight loss vs 8% with Saxenda in clinical trials. Compare evidence, side effects, dosing, and UK costs.

Wegovy produces 15.8% weight loss vs 6.4% with Saxenda in a head-to-head trial. Compare clinical evidence, side effects, dosing, and UK costs.

heySlim vs Second Nature: Compare doctor-led prescriptions vs dietitian-led coaching for Mounjaro and Wegovy. Pricing, reviews, and support compared.